TED Ted Baker Plc

 

TIDMTED 
 
RNS Number : 7143M 
Gen-Probe Incorporated 
03 February 2009 
 

Not for release, publication or distribution, in whole or in part, in, into or 
from any jurisdiction where to do so would constitute a violation of the 
relevant laws of such jurisdiction 
 
 
3 February 2009 
 
TEPNEL LIFE SCIENCES PLC OFFER UPDATE 
 
 
On 30 January 2009, the directors of Gen-Probe and Tepnel announced a 
recommended cash offer for the entire and to be issued share capital of Tepnel. 
 
 
On 30 January 2009, Gen-Probe received an irrevocable undertaking from Artemis 
Investment Management to vote in favour of the Scheme and the resolutions at the 
Court Meeting and the GM in respect of its entire holding of 4,567,061 Tepnel 
Shares, representing approximately 1.91 per cent. of the existing issued share 
capital of Tepnel. 
 
 
This irrevocable undertaking ceases to be binding if: (i) the Scheme Document is 
not posted by 27 February 2009 (or such later date as the Panel may agree); (ii) 
the Offer lapses or does not become effective, lapses or is withdrawn in 
accordance with its terms; or (iii) upon the announcement of a competing offer 
at a price of at least 10 per cent. above the value of the Offer. 
 
 
As a result of this announcement, Gen-Probe has therefore received total 
irrevocable undertakings in respect of Tepnel Shares representing approximately 
42 per cent. of the existing issued share capital of Tepnel. 
 
 
Words and expressions defined in the announcement dated 30 January 2009 shall, 
unless the context otherwise requires, have the same meanings when used in this 
announcement. 
 
 
Enquiries: 
 
 
+---------------------------------------------+----------------------------+ 
| GEN-PROBE INCORPORATED                      | Telephone: +1 858 410 8000 | 
| Herm Rosenman, Senior Vice President and    |                            | 
| Chief Financial Officer                     |                            | 
| Michael Watts, Senior Director, Investor    |                            | 
| Relations                                   |                            | 
|                                             |                            | 
+---------------------------------------------+----------------------------+ 
 
 
Dealing Disclosure Requirements 
Under the provisions of Rule 8.3 of the Code, if any person is, or becomes, 
"interested" (directly or indirectly) in 1 per cent. or more of any class of 
"relevant securities" of Tepnel, all "dealings" in any "relevant securities" of 
Tepnel (including by means of an option in respect of, or a derivative 
referenced to, any such "relevant securities") must be publicly disclosed by no 
later than 3.30 p.m. (London time) on the Business Day following the date of the 
relevant transaction. This requirement will continue until the date on which the 
Scheme becomes effective or lapses or on which the "offer period" otherwise 
ends. If two or more persons act together pursuant to an agreement or 
understanding, whether formal or informal, to acquire an "interest" in "relevant 
securities" of Tepnel, they will be deemed to be a single person for the purpose 
of Rule 8.3. 
Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant 
securities" of Tepnel by Gen-Probe or Tepnel, or by any of their respective 
"associates", must be disclosed by no later than 12.00 noon (London time) on the 
Business Day following the date of the relevant transaction. 
A disclosure table, giving details of the companies in whose "relevant 
securities" "dealings" should be disclosed, and the number of such securities in 
issue, can be found on the Panel's website at www.thetakeoverpanel.org.uk. 
"Interests in securities" arise, in summary, when a person has long economic 
exposure, whether conditional or absolute, to changes in the price of 
securities. In particular, a person will be treated as having an "interest" by 
virtue of the ownership or control of securities, or by virtue of any option in 
respect of, or derivative referenced to, securities. 
Terms in quotation marks are defined in the Code, which can also be found on the 
Panel's website. If you are in any doubt as to whether or not you are required 
to disclose a "dealing" under Rule 8, please contact an independent financial 
adviser authorised under the Financial Services and Markets Act 2000, consult 
the Panel's website at www.thetakeoverpanel.org.uk or contact the Panel on 
telephone number +44 (0) 20 7638 0129; fax +44 (0) 20 7236 7013. 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 OUPCKNKDNBKDABK 
 

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024